https://www.jonesday.com/en/practices/experience/2010/07/celgene-acquires-abraxis-bioscience-for-29-billion
Jones Day advised Celgene Corporation in its $2.9 billion merger with Abraxis BioScience Inc. Under the terms of the merger agreement, each share of Abraxis...
abraxis biosciencecelgeneacquiresbillionexperience